Anneleen Daemen

8.3k citations

104 papers · 4.0k indexed · 3 hit papers · h-index 33

Cancer Research top 1%
- Cancer Genomics and Diagnostics 11
- Cancer, Hypoxia, and Metabolism 10
Obstetrics and Gynecology top 1%
- Pregnancy and preeclampsia studies 7
Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment 9
Genetics top 2%
- Estrogen and related hormone effects 9
Oncology top 5%
Molecular Biology
- Gene expression and cancer classification 11
Public Health, Environmental and Occupational Health
- Ectopic Pregnancy Diagnosis and Management 11
Pulmonary and Respiratory Medicine
- Advanced Breast Cancer Therapies 8

Co-authors: Bart De Moor D. Timmerman Olivier Gevaert T. Bourne Joe W. Gray Laura van ‘t Veer Georgia Hatzivassiliou Luika Timmerman
Cited by: Cancer Research Obstetrics and Gynecology Reproductive Medicine
Partner nations: Belgium United States United Kingdom

In The Last Decade

Anneleen Daemen

97 papers receiving 3.9k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2021 Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer
2013 Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target
2009 Intrinsic Gene Expression Profiles of Gliomas Are a Better Predictor of Survival than Histology

Peers

Countries citing papers authored by Anneleen Daemen

Since Specialization

Citations

This map shows the geographic impact of Anneleen Daemen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anneleen Daemen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anneleen Daemen more than expected).

Fields of papers citing papers by Anneleen Daemen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anneleen Daemen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anneleen Daemen. The network helps show where Anneleen Daemen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Anneleen Daemen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anneleen Daemen Line = papers co-authored together Anneleen Daemen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer M. Dorso,Payal T. Patel,Aleksandr Pankov,Jacob A. Boyer,Rajesh K. Soni,Isabella Del Priore,Omar Hayatt,Amanda Kulick,Connor J. Hagen,Elisa de Stanchina,Melissa R. Junttila,Anneleen Daemen,Lori S. Friedman,Ronald C. Hendrickson,Sarat Chandarlapaty	2023	2
2	1333P A global phase 1b study of ORIC-114, a highly selective, brain penetrant EGFR and HER2 inhibitor, in patients with advanced solid tumors harboring EGFR Exon 20 or HER2 alterations Min Hee Hong,Alexander I. Spira,Ki Hyeong Lee,E.K. Cho,J-Y. Han,Byoung Yong Shim,JS Lee,S.C-H. Kao,S-W. Kim,Adnan Khattak,Mayank Patel,Rongda Xu,J. Wang,Eric A. Ariazi,Anneleen Daemen,Edna Chow Maneval,Pratik S. Multani,Roopal Patel,M-J. Ahn	2023	5
3	ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer Radia Marie Johnson,Xueping Qu,Chu-Fang Lin,Ling‐Yuh Huw,Avinashnarayan Venkatanarayan,Ethan Sokol,Fang‐Shu Ou,Nnamdi Ihuegbu,Oliver A. Zill,Omar Kabbarah,Lisa Wang,Richard Bourgon,Felipe de Sousa e Melo,Chris Bolen,Anneleen Daemen,Alan P. Venook,Federico Innocenti,Heinz‐Josef Lenz,Carlos Bais	2022	24
4	Giredestrant reverses progesterone hypersensitivity driven by estrogen receptor mutations in breast cancer Jackson Liang,Ellen Ingalla,Xiaosai Yao,Bu-Er Wang,Lisa Tai,Jennifer M. Giltnane,Yuxin Liang,Anneleen Daemen,Heather M. Moore,Junko Aimi,Ching‐Wei Chang,Mary Gates,Jennifer Eng‐Wong,Lucinda Tam,Natasha Bacarro,Merone Roose‐Girma,Meritxell Bellet,Marc Hafner,Ciara Metcalfe	2022	9
5	Transcriptional Subtypes Resolve Tumor Heterogeneity and Identify Vulnerabilities to MEK Inhibition in Lung Adenocarcinoma Anneleen Daemen,Jonathan E. Cooper,Szymon Myrta,Matthew Wongchenko,Eva Lin,Jason E. Long,Oded Foreman,Zora Modrušan,Jarrod R. Tremayne,Cecile C. de la Cruz,Mark Merchant,Scott E. Martin,Yibing Yan,Melissa R. Junttila	2020	11
6	Development of a gene expression–based prognostic signature for IDH wild-type glioblastoma Radia Marie Johnson,Heidi Phillips,Carlos Bais,Cameron Brennan,Timothy F. Cloughesy,Anneleen Daemen,Ulrich Herrlinger,Robert B. Jenkins,Albert Lai,Christoph Mancao,Michael Weller,Wolfgang Wick,Richard Bourgon,Josep Garcia	2020	19
7	Integrated digital pathology and transcriptome analysis identifies molecular mediators of T-cell exclusion in ovarian cancer Mélanie Desbois,Akshata R. Udyavar,Lisa Ryner,Cleopatra Kozlowski,Yinghui Guan,Milena Dürrbaum,Shan Lu,Jean‐Philippe Fortin,Hartmut Koeppen,James Ziai,Ching‐Wei Chang,Shilpa Keerthivasan,Marie Plante,Richard Bourgon,Carlos Bais,Priti S. Hegde,Anneleen Daemen,Shannon J. Turley,Yulei Wang	2020	139
8	Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging Denise P. Muñoz,Steven M. Yannone,Anneleen Daemen,Yu Sun,Funda Vakar‐Lopez,Misako Kawahara,Adam Freund,Françis Rodier,Jennifer D. Wu,Pierre-Yves Desprez,David H. Raulet,Peter S. Nelson,Laura van ‘t Veer,Judith Campisi,Jean-Philippe Coppé	2019	118
9	Genomic Alterations Associated with Recurrence and TNBC Subtype in High-Risk Early Breast Cancers Timothy R. Wilson,Akshata R. Udyavar,Ching‐Wei Chang,Jill M. Spoerke,Junko Aimi,Heidi Savage,Anneleen Daemen,Joyce O’Shaughnessy,Richard Bourgon,Mark R. Lackner	2018	15
10	HER2 is not a cancer subtype but rather a pan-cancer event and is highly enriched in AR-driven breast tumors Anneleen Daemen,Gerard Manning	2018	39
11	Metabolic and transcriptional profiling reveals pyruvate dehydrogenase kinase 4 as a mediator of epithelial-mesenchymal transition and drug resistance in tumor cells Yuting Sun,Anneleen Daemen,Georgia Hatzivassiliou,David Arnott,Catherine Wilson,Guanglei Zhuang,Min Gao,Peter Liu,Aaron Boudreau,Leisa Johnson,Jeff Settleman	2014	98
12	Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Targetbreakdown → Luika Timmerman,Thomas Holton,Mariia Yuneva,Raymond J. Louie,Mercè Padró,Anneleen Daemen,Min Hu,Denise A. Chan,Stephen P. Ethier,Laura van ‘t Veer,Kornélia Polyák,Frank McCormick,Joe W. Gray	2013	471
13	Loss of Cell-Surface Laminin Anchoring Promotes Tumor Growth and Is Associated with Poor Clinical Outcomes Armin Akhavan,Obi L. Griffith,Liliana Soroceanu,Dmitri Leonoudakis,Maria Gloria Luciani-Torres,Anneleen Daemen,Joe W. Gray,John Muschler	2012	53
14	An update on the genomic landscape of breast cancer: new opportunity for personalized therapy? Anneleen Daemen	2012	5
15	A Seven-Gene Set Associated with Chronic Hypoxia of Prognostic Importance in Hepatocellular Carcinoma Hannah van Malenstein,Olivier Gevaert,Louis Libbrecht,Anneleen Daemen,Joke Allemeersch,Frederik Nevens,Eric Van Cutsem,David Cassiman,Bart De Moor,Chris Verslype,Jos van Pelt	2010	49
16	Effect of cancer prevalence on the use of risk‐assessment cut‐off levels and the performance of mathematical models to distinguish malignant from benign adnexal masses Anneleen Daemen,D. Jurkovic,C. Van Holsbeke,S. Guerriero,A. C. Testa,Artur Czekierdowski,Robert Fruscio,D. Paladini,Patrick Neven,A. Rossi,T. Bourne,Bart De Moor,D. Timmerman	2010	2
17	Intrinsic Gene Expression Profiles of Gliomas Are a Better Predictor of Survival than Histologybreakdown → Lonneke A.M. Gravendeel,Mathilde C.M. Kouwenhoven,Olivier Gevaert,Johan J. de Rooi,Andrew Stubbs,J. Elza Duijm,Anneleen Daemen,Fonnet E. Bleeker,Linda B.C. Bralten,Nanne K. Kloosterhof,Bart De Moor,Paul H.C. Eilers,Peter J. van der Spek,Johan M. Kros,Peter A.E. Sillevis Smitt,Martin J. van den Bent,Pim J. French	2009	512
18	PREDICTING LYMPH NODE INVOLVEMENT OF BREAST CANCER BY USING GENE EXPRESSION PROFILES Ann Smeets,Anneleen Daemen,Hans Wildiers,Isabelle Vanden Bempt,Robert Paridaens,Rose Christiaens	2009	1
19	Ultrasound Experience Substantially Impacts on Diagnostic Performance and Confidence when Adnexal Masses Are Classified Using Pattern Recognition Caroline Van Holsbeke,Anneleen Daemen,J. Yazbek,Tom Holland,T. Bourne,Tinne Mesens,Lore Lannoo,Anne‐Sophie Boes,Annelies Joos,Arne van de Vijver,Nele Roggen,Bart De Moor,Evert de Jonge,A. C. Testa,L. Valentin,D. Jurkovic,D. Timmerman	2009	46
20	Recurrent copy number alterations inBRCA1-mutated ovarian tumors alter biological pathways Karin Leunen,Olivier Gevaert,Anneleen Daemen,Vanessa Vanspauwen,GeneviÃ ̈ve Michils,Bart De Moor,Philippe Moerman,Ignace Vergote,Eric Legius	2009	7

About Anneleen Daemen

Anneleen Daemen is a scholar working on Obstetrics and Gynecology, Cancer Research and Reproductive Medicine, having authored 104 papers that have together received 4.0k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (11 papers), Gene expression and cancer classification (11 papers), Ectopic Pregnancy Diagnosis and Management (11 papers), Cancer, Hypoxia, and Metabolism (10 papers), Ovarian cancer diagnosis and treatment (9 papers), Estrogen and related hormone effects (9 papers), Advanced Breast Cancer Therapies (8 papers) and Pregnancy and preeclampsia studies (7 papers). The work is most often cited by research in Cancer Research (1.2k citations), Obstetrics and Gynecology (523 citations) and Reproductive Medicine (460 citations). Anneleen Daemen has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Bart De Moor, D. Timmerman, Olivier Gevaert, T. Bourne, Joe W. Gray, Bart De Moor, Laura van ‘t Veer, Georgia Hatzivassiliou, Luika Timmerman and Mercè Padró.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact